Poukalov Konstantin

CIK 00016787368 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001678736

Recent Transactions

26 trades

Award
Lyra Therapeutics, Inc.$LYRA
Stock Option
2024-06-13+30,000→ 30,000 total
Exercise/Conversion
LianBio$LIANY
Ordinary Shares
2024-02-15$2.52/sh+36,300→ 36,300 total
Exercise/Conversion
LianBio$LIANY
Stock Option (Right to Buy)
2024-02-15−36,300→ 0 total
Tax Payment
LianBio$LIANY
Ordinary Shares
2024-02-15$4.76/sh−19,218→ 17,082 total
Award
Lyra Therapeutics, Inc.$LYRA
Stock Option
2023-06-30+20,000→ 20,000 total
Award
LianBio$LIANY
Stock Option (Right to Buy)
2023-06-21+36,300→ 36,300 total
Award
LianBio$LIANY
Stock Option (Right to Buy)
2022-06-23+36,300→ 36,300 total
Award
Lyra Therapeutics, Inc.$LYRA
Stock Option
2022-06-16+7,250→ 7,250 total
Award
Lyra Therapeutics, Inc.$LYRA
Stock Option
2021-05-26+7,250→ 7,250 total
Purchase
Landos Biopharma, Inc.
Common Stock
2021-02-09$13.80/sh+64,730→ 14,834,964 total
Purchase
Landos Biopharma, Inc.
Common Stock
2021-02-09$14.60/sh+34,951→ 14,869,915 total
Purchase
Landos Biopharma, Inc.
Common Stock
2021-02-08$12.53/sh+86,671→ 14,768,463 total
Conversion
Landos Biopharma, Inc.
Series A Preferred Stock
2021-02-08−5,883,538→ 0 total
Conversion
Landos Biopharma, Inc.
Common Stock
2021-02-08+13,369,728→ 13,369,728 total
Purchase
Landos Biopharma, Inc.
Common Stock
2021-02-08$16.00/sh+1,250,000→ 14,619,728 total
Conversion
Landos Biopharma, Inc.
Series B Preferred Stock
2021-02-08−7,486,190→ 0 total
Purchase
Landos Biopharma, Inc.
Common Stock
2021-02-08$11.38/sh+34,611→ 14,681,792 total
Purchase
Landos Biopharma, Inc.
Common Stock
2021-02-08$13.10/sh+1,771→ 14,770,234 total
Purchase
Landos Biopharma, Inc.
Common Stock
2021-02-05$11.14/sh+27,453→ 14,647,181 total
Award
Lyra Therapeutics, Inc.$LYRA
Stock Option
2020-04-30+14,500→ 14,500 total
Award
Kadmon Holdings, Inc.
Stock Appreciation Right
2017-12-08+205,000→ 205,000 total
Award
Kadmon Holdings, Inc.
Stock Option (right to buy)
2016-12-15$4.66/sh+350,000→ 350,000 total
Purchase
Kadmon Holdings, Inc.
Common stock, par value $0.001
2016-11-11$5.96/sh+1,000→ 1,000 total
Purchase
Kadmon Holdings, Inc.
Common stock, par value $0.001
2016-11-11$5.91/sh+1,000→ 2,000 total
Purchase
Kadmon Holdings, Inc.
Common stock, par value $0.001
2016-11-11$5.95/sh+1,000→ 3,000 total
Purchase
Kadmon Holdings, Inc.
Common stock, par value $0.001
2016-11-11$5.43/sh+1,000→ 4,000 total

Companies

Recent Filings

Address

C/O KADMON HOLDINGS, INC. 450 E 29TH STREET

NEW YORK, NY, 10016

View on SEC.gov